$16.06 $0.13 per serving
Product analysis
Huperzine A 100 mcg offers an economical, single-ingredient option aimed at memory-related support. Its effects on a brain messenger do not establish better memory in healthy adults.
AI assessment of the formula, label and price. How scoring works
Nutrient Quality40
The Huperzia leaf extract source is identified. Its name alone does not establish preparation quality or an absorption advantage.
Ingredient Transparency100
The huperzine amount and botanical source are clearly stated. That makes the serving straightforward to compare with similar supplements.
Value For Money100
The huperzine contribution is economical for the declared amount. Price is a clear appeal for shoppers comparing the same active ingredient.
Customer Satisfaction81
Customer feedback is very positive across a substantial number of ratings. The review volume supports a useful satisfaction picture without proving cognitive benefits.
Product Focus63
A single active ingredient keeps the formula focused on memory-related functions. Effects on brain signalling and findings in disease-treatment settings do not establish routine cognitive improvement in healthy adults.
- Format
Tablet - Container
- 120 Tablet(s)
- Per serving
- $0.13
- Also available
Huperzine A 200 mcg$25.89- Customer rating
- 4.6 · 1,619 ratings
Goals
Impact
Lower effect
Huperzine · 100 mcg
Impact
Highest effect
Huperzine · 100 mcg
Huperzine inhibits the enzyme that breaks down acetylcholine, a messenger involved in memory. This mechanism and the supplied Alzheimer-disease trial do not establish routine cognitive improvement in healthy adults. The 100 mcg serving reaches the saved exposure comparison, but treatment-cohort dosing cannot be transferred to a general supplement benefit. The Huperzia source does not remove that distinction.
How this product is rated for Cognitive Support
Ingredient fit95
Huperzine is the sole counted ingredient. The 100 mcg serving reaches the saved exposure comparison.
Goal fit
Huperzine is the sole counted ingredient.
Dose adequacy
The 100 mcg serving reaches the saved exposure comparison.
Pathways60
Acetylcholine signalling is the sole represented pathway.
Depth
Acetylcholine signalling is the sole represented pathway.
Breadth
One pathway reaches the saved coverage threshold, leaving other cognitive routes unrepresented.
Evidence91
The supplied clinical evidence concerns Alzheimer disease rather than general healthy-adult performance.
Evidence strength
The supplied clinical evidence concerns Alzheimer disease rather than general healthy-adult performance.
Studied preparation
The counted ingredients receive a saved preparation match; this alone does not demonstrate improved cognition.
Formulation logic100
The counted ingredients meet the saved minimum exposure threshold, with no missing required partner or configured conflict.
Partner coverage
The counted ingredients have no missing required partner; this does not establish an added benefit from combining them.
Conflicts
No configured ingredient conflict was identified; this is not a general safety assessment.
Effective doses
All counted ingredients meet the saved minimum exposure threshold; this does not establish clinically effective cognitive doses.
Impact
Highest effect
Huperzine · 100 mcg
Huperzine affects acetylcholine signalling, which is involved in memory and attention. That mechanism and findings from disease-treatment trials do not establish routine cognitive benefits in healthy adults. The supplied findings therefore support a mechanistic connection, rather than a promise of better memory.
How this product is rated for Brain Health
Ingredient fit95
The relevant ingredients are concentrated on this goal, although the product is also linked to other uses. The amounts receive full recognition in the saved comparison; that does not establish an optimal personal dose.
Goal fit
The relevant ingredients are concentrated on this goal, although the product is also linked to other uses.
Dose adequacy
The amounts receive full recognition in the saved comparison; that does not establish an optimal personal dose.
Pathways54
The mapped emphasis is acetylcholine signalling. Coverage elsewhere is limited.
Depth
The strongest mapped contribution concerns acetylcholine signalling; this describes the ingredient connection, not a demonstrated cognitive outcome.
Breadth
Substantial coverage is concentrated in one mapped area rather than spread across several aspects of brain function.
Evidence90
The saved findings give Huperzine the leading evidence position. Its biological role and the supplied population and preparation limits determine the practical claim.
Evidence strength
Huperzine leads the saved evidence comparison, but the supplied scientific limitations still constrain what cognitive benefits can be expected.
Studied preparation
The saved findings accept the preparations used in the comparison; this alone does not prove equivalent cognitive benefits for every declared form.
Formulation logic100
No unmet partner requirement or configured conflict was identified. Amount thresholds describe the saved comparison and do not establish extra benefit from the combination.
Partner coverage
The relevant ingredients have no unmet partner requirement in the supplied findings; this does not establish an added benefit from combining them.
Conflicts
No configured ingredient conflict was identified in the supplied findings.
Effective doses
The counted ingredients pass the saved minimum amount threshold; that threshold is not proof of cognitive effectiveness.
Impact
Lower effect
Huperzine · 100 mcg
Huperzine Not classified
No linked studies yet.
Ingredients
| Ingredient | Amount per serving | Score |
|---|---|---|
Huperzine A (Huperzia serrata Leaf Extract) | 100 mcg |
Huperzine (Huperzia serrata Leaf Extract) · 100 mcg OverallScore79
The serving lists 100 mcg of Huperzine A. The whole-product price works out to about $0.13 per 100 mcg of Huperzine A, which is relatively low.
How this ingredient is rated
Active Ingredient Quality & Bioavailability60
The saved facts identify Huperzia serrata extract, but do not establish its Huperzine A concentration.
Source and Standardization Clarity
A Huperzia serrata extract is identified; its standardization percentage is not established by the available facts.
Dose, Safety & Label Transparency88
The serving lists 100 mcg of Huperzine A. No specific cycling guidance is recorded in the saved facts.
Huperzine A Dosage Efficacy
The serving lists 100 mcg of Huperzine A.
Cycling Guidance and Transparency
The active amount is specified, but no specific cycling guidance is recorded in the saved facts.
Value100
The whole-product price works out to about $0.13 per 100 mcg of Huperzine A, which is relatively low.
Price per 100mcg of Huperzine A
Based on the whole-product price, 100 mcg of Huperzine A costs about $0.13, which is relatively low.
Alternative products
Report alternatives
Sources
Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.
- Huperzine a in the treatment of Alzheimer's disease and vascular dementia: a meta-analysis.
- [Clinical efficacy and safety of huperzine Alpha in treatment of mild to moderate Alzheimer disease, a placebo-controlled, double-blind, randomized trial].
- Huperzine A associated with improved early postoperative cognitive function after neurosurgery under general anesthesia: a randomized clinical trial.
- Treatment with Huperzine A improves cognition in vascular dementia patients.
- Huperzine-A response to cognitive impairment and task switching deficits in patients with Alzheimer's disease.
- Adjunctive huperzine A for cognitive deficits in schizophrenia: a systematic review and meta-analysis.
- [Drug evaluation of huperzine A in the treatment of senile memory disorders].
- Effect of Huperzine A on Cognitive Function and Perception of Effort during Exercise: A Randomized Double-Blind Crossover Trial.